Despite a stellar 38% gain over the past year, analysis suggests Federated Hermes (NYSE: FHI) shares may still be trading at a discount to their intrinsic value, presenting a potential opportunity in the capital markets sector.
A revised price target for Haivision Systems (TSX:HAI) is shifting the investment narrative, prompting a closer look at the video streaming technology firm's prospects amid evolving market conditions.
Bloom Energy's landmark $2.65 billion power agreement and a potential $5 billion infrastructure partnership signal a strategic pivot to become a cornerstone provider for the energy-hungry AI data center industry, prompting a fresh look at its long-term valuation.
An analysis of Mooreast Holdings' financial metrics reveals a worrying trend of declining returns on capital employed, despite growth in its asset base. The company's performance lags behind its own historical figures, prompting a closer look from the market.
Integra Resources Corp. has reported its 2025 operational results from the Florida Canyon Mine, with annual production reaching 70,927 ounces of gold. While the figures confirm the mine's established scale, analysts suggest the real investment narrative hinges on the development of the larger DeLamar project and ongoing financial metrics.
Novo Nordisk's newly launched oral GLP-1 drug, amycretin, has seen explosive initial demand in the U.S., potentially setting the stage for a significant financial turnaround and stock rally after a challenging previous year.
Apple shares edged higher following a robust Q1 earnings report headlined by record iPhone revenue, yet the muted gains reflect Wall Street's growing focus on looming supply constraints and the company's strategic pivot to artificial intelligence.
Bank of America has revised its price target for consumer goods giant Kimberly-Clark downward, citing sector-wide valuation pressures, even as the company reports resilient earnings and advances its transformation into a broader health and wellness player.
Hitachi, Ltd. announces a ¥100 billion share repurchase and a sweeping leadership reshuffle across its core divisions, sharpening its focus on digital and AI-driven growth. While the move underscores a commitment to shareholder returns and a transformed future, analysts caution that execution risks and a premium valuation loom large.
Capgemini faces mounting scrutiny after its U.S. subsidiary signed a contract with Immigration and Customs Enforcement (ICE), sparking ethical debates in France and raising questions about governance risks for the IT consulting giant.
With low adoption rates for brokerage 'trusted contacts,' regulators are considering a simple name change to 'emergency contact' to reduce confusion, ease client concerns, and strengthen protections against financial exploitation.
While stocks priced between $10 and $50 often signal companies past their initial hurdles, some still grapple with unproven models and market volatility. We examine three such stocks where the risk may outweigh the potential reward.
While the healthcare sector has surged 17.4% in six months, outpacing the S&P 500, regulatory headwinds and valuation concerns demand a selective approach. We examine one stock with a durable edge and two facing significant challenges.
While small-cap stocks can offer overlooked opportunities, their high-risk nature demands careful scrutiny. We examine three companies where valuation and business concerns suggest caution may be warranted.
Hershey (HSY) shares are drawing renewed attention from Wall Street as upbeat earnings sentiment converges with the launch of its innovative Jolly Rancher Heat Wave Gummies. While recent momentum is strong, valuation metrics present a complex picture for the iconic confectioner.
Honeywell International posts a robust Q4 with record orders and backlog, while announcing an accelerated timeline to spin off its core Aerospace business as a standalone public company by late 2026, a move set to redefine its investment profile.
In a bid to attract new entrants to the market, financial services firm SoFi is offering a significant stock bonus of up to $1,000 for opening a self-directed investment account, eliminating traditional barriers like commissions and minimums.
While the S&P 500 has climbed, Walker & Dunlop shares have tumbled over 14% in six months. We analyze the underlying weaknesses in its financials and highlight a more compelling opportunity for value-focused portfolios.
While small-cap stocks can offer unique growth opportunities away from Wall Street's spotlight, their inherent risks demand careful scrutiny. We examine three companies where valuation concerns and competitive pressures suggest caution may be warranted.
DexCom Inc. (DXCM) has released preliminary Q4 figures that exceeded expectations and provided robust long-term guidance, reinforcing its position as a favored pick among analysts and hedge funds in the medical devices sector.
